Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders

肺动脉高压 医学 高原肺水肿 缺氧性肺血管收缩 缺氧(环境) 心脏病学 适应不良 高海拔对人类的影响 内科学 硝苯地平 肺动脉 高原病 肺水肿 重症监护医学 有机化学 化学 氧气 精神科 解剖
作者
Akylbek Sydykov,Argen Mamazhakypov,Abdirashit Maripov,Djuro Kosanovic,Norbert Weißmann,Hossein Ardeschir Ghofrani,Akpay Sarybaev,Ralph T. Schermuly
出处
期刊:International Journal of Environmental Research and Public Health [Multidisciplinary Digital Publishing Institute]
卷期号:18 (4): 1692-1692 被引量:137
标识
DOI:10.3390/ijerph18041692
摘要

Alveolar hypoxia is the most prominent feature of high altitude environment with well-known consequences for the cardio-pulmonary system, including development of pulmonary hypertension. Pulmonary hypertension due to an exaggerated hypoxic pulmonary vasoconstriction contributes to high altitude pulmonary edema (HAPE), a life-threatening disorder, occurring at high altitudes in non-acclimatized healthy individuals. Despite a strong physiologic rationale for using vasodilators for prevention and treatment of HAPE, no systematic studies of their efficacy have been conducted to date. Calcium-channel blockers are currently recommended for drug prophylaxis in high-risk individuals with a clear history of recurrent HAPE based on the extensive clinical experience with nifedipine in HAPE prevention in susceptible individuals. Chronic exposure to hypoxia induces pulmonary vascular remodeling and development of pulmonary hypertension, which places an increased pressure load on the right ventricle leading to right heart failure. Further, pulmonary hypertension along with excessive erythrocytosis may complicate chronic mountain sickness, another high altitude maladaptation disorder. Importantly, other causes than hypoxia may potentially underlie and/or contribute to pulmonary hypertension at high altitude, such as chronic heart and lung diseases, thrombotic or embolic diseases. Extensive clinical experience with drugs in patients with pulmonary arterial hypertension suggests their potential for treatment of high altitude pulmonary hypertension. Small studies have demonstrated their efficacy in reducing pulmonary artery pressure in high altitude residents. However, no drugs have been approved to date for the therapy of chronic high altitude pulmonary hypertension. This work provides a literature review on the role of pulmonary hypertension in the pathogenesis of acute and chronic high altitude maladaptation disorders and summarizes current knowledge regarding potential treatment options.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
星辰大海应助wulin314采纳,获得10
刚刚
CL完成签到 ,获得积分10
1秒前
MQRR发布了新的文献求助10
1秒前
Ono完成签到,获得积分10
2秒前
星辰大海应助lshcraft采纳,获得10
2秒前
wqh发布了新的文献求助10
2秒前
hanjresearch发布了新的文献求助10
2秒前
lili完成签到,获得积分10
3秒前
ys完成签到,获得积分10
5秒前
6秒前
6秒前
7秒前
己凡完成签到,获得积分10
8秒前
丘比特应助愉快啊啊采纳,获得10
9秒前
小马甲应助王木木采纳,获得10
9秒前
ffw1发布了新的文献求助10
9秒前
WaterBru完成签到,获得积分10
9秒前
丘比特应助无机盐采纳,获得10
11秒前
12秒前
小高完成签到 ,获得积分10
12秒前
SHIMMER发布了新的文献求助10
12秒前
zhiyuan完成签到,获得积分10
13秒前
13秒前
阴暗蘑菇完成签到 ,获得积分10
14秒前
hanjresearch完成签到,获得积分10
16秒前
酷波er应助曾经很有自信采纳,获得10
16秒前
笨笨不乐完成签到,获得积分10
16秒前
17秒前
17秒前
17秒前
LUAN完成签到,获得积分10
17秒前
17秒前
猪猪hero发布了新的文献求助10
18秒前
夏洳完成签到,获得积分10
18秒前
19秒前
xingzi123完成签到 ,获得积分10
20秒前
20秒前
小杨发布了新的文献求助10
21秒前
刘小木发布了新的文献求助10
21秒前
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Principles of town planning: translating concepts to applications 1000
Navigating Normative Orders. Interdisciplinary Perspectives 800
1 Peter and Christ's Descent to the Dead in Its Early Christian Reception 700
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7740600
求助须知:如何正确求助?哪些是违规求助? 9289208
关于积分的说明 20194548
捐赠科研通 7318799
什么是DOI,文献DOI怎么找? 3306487
关于科研通互助平台的介绍 2458764
邀请新用户注册赠送积分活动 2316612